New evidence shows that the drug makers Merck and Schering-Plough have conducted several studies of their popular cholesterol medicine Zetia that raise questions about its risks to the liver, but the companies have never published those results.
Read More »Diabetes In Control
Neuropathic Pain Effectively Treated by Cannabis
Smoked cannabis eased pain induced in healthy volunteers, according to a study by researchers at the University of California, San Diego (UCSD) Center for Medical Cannabis Research (CMCR.) However, the researchers found that less may be more.
Read More »Double Whammy: Birth Control Pills + Diabetes
A provocative study presented at the AHA has found an association between long-term use of birth control pills and buildup of plaque in arteries in the neck and legs, which could be a sign of heart disease.
Read More »Walk, to Prevent or Reverse PreDiabetes
For overweight or obese individuals who are physically inactive, brisk walking might be the best exercise prescription for shedding excess pounds and reducing the risk of metabolic syndrome and prediabetes.
Read More »Pioglitazone Lowers Cardiovascular Risk in Diabetic Patients with Kidney Disease
A new study confirms that chronic kidney disease (CKD) increases the already-high risk of serious cardiovascular events in diabetic patients with damage to the large blood vessels and suggests that treatment with the anti-diabetic drug pioglitazone may help to lower this risk.
Read More »Current Body Wt. More Than Birth Rate for Diabetes Risk
In adults, the development of insulin resistance, a precursor to diabetes, is influenced more by current body weight than by birth weight, results of a study in twins suggests.
Read More »Newly Found Gene Important in Fat Storage
Scientists report the discovery of a previously unknown gene family that plays a key role in whether or not cells store fat, a discovery that could lead to new approaches to obesity and related diseases.
Read More »Insulin Aspart and Lispro Equivlent for Insulin Pumps
A group of investigators led by Dr Stuart Weinzimer of Yale University School of Medicine in New Haven, CT, USA, compared the safety and efficacy of continuous subcutaneous insulin infusion (CSII) using insulin aspart with insulin lispro in children and adolescents with type 1 diabetes.
Read More »Unlikely Angina Drug Improves A1c
Antianginal agent, ranolazine, reduced incidence of newly increased HbA1c in people without diabetes.
Read More »Obesity Carries High Costs in Worker Absenteeism
Obesity and morbid obesity are associated with increased rates of work absenteeism, with estimated costs of $4.3 billion per year in the United States.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.